May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Sankalp Arora: Sharing our ASCO25 Abstract – Relapse Mechanisms After FLT3i therapy in Frontline AML
May 24, 2025, 07:00

Sankalp Arora: Sharing our ASCO25 Abstract – Relapse Mechanisms After FLT3i therapy in Frontline AML

Sankalp Arora, Hematology/Medical Oncology Fellow at MD Anderson Cancer Center, shared in a post on X:

“Sharing our ASCO25 abstract: relapse mechanisms after FLT3i rx in frontline AML.

FLT3 loss and emergent DNA methylation/RAS-MAPK/WT1 mutations were common at relapse. Post SCT relapses were less likely to be driven by emergent mutations.”